Citation：
雷证, 罗吉, 陈冬菊, 陈琴, 杨浩, 王波, 张远军. 体外膜氧合治疗H5N6重症禽流感患者一例. Chinese Journal of Respiratory and Critical Care Medicine, 2025, 24(1): 51-53. doi: 10.7507/1671-6205.202403041
Copy
Copyright © the editorial department of Chinese Journal of Respiratory and Critical Care Medicine of West China Medical Publisher. All rights reserved
| 1. |
Wang L, Wang D, Zhang T, et al. Extracorporeal membrane oxygenation for COVID-19 and influenza associated acute respiratory distress syndrome: a systematic review. Expert Rev Respir Med, 2023, 17(10): 951-959.
|
| 2. |
郭振东. H5N6亚型禽流感病毒跨种感染哺乳动物的致病与传播风险研究. 军事科学院, 2019.
|
| 3. |
刘丽娜, 赵宗正, 郭振东, 等. 人感染H5N6亚型禽流感病毒研究进展. 军事医学, 2017, 41(1): 69-72.
|
| 4. |
Surveillance Division of the Communicable Disease Branch of the Centre for Health Protection (2023). Avian Influenza Report, volume 19 (China: Department of Health, Government of the Hong Kong Special Administrative Region), number 30. https://www.chp.gov.hk/files/pdf/ 2023_avian_influenza_report_vol19_wk30.pdf.
|
| 5. |
Pan M, Gao R, Lv Q, et al. Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: Virological and clinical findings. J Infect, 2016, 72(1): 52-59.
|
| 6. |
Steven JL, Vincent AP, Warwick B, et al. Extracorporeal membrane oxygenation. Med J Aust, 2009, 191(3): 178-182.
|
| 7. |
张伟明, 方树珊, 唐松元, 等. 奥司他韦对高致病性H5N6亚型禽流感病毒的抑制效果评价. 现代畜牧兽医, 2019(8): 12-16.
|
| 8. |
Guan W, Qu R, Shen L, et al. Baloxavir marboxil use for critical human infection of avian influenza A H5N6 virus. Med, 2024, 5(1): 32-41.
|
| 9. |
Wu W, Shi Y, Gao H, et al. Immune derangement occurs in patients with H7N9 avian influenza. Crit Care, 2014, 18(2): R43.
|
- 1. Wang L, Wang D, Zhang T, et al. Extracorporeal membrane oxygenation for COVID-19 and influenza associated acute respiratory distress syndrome: a systematic review. Expert Rev Respir Med, 2023, 17(10): 951-959.
- 2. 郭振东. H5N6亚型禽流感病毒跨种感染哺乳动物的致病与传播风险研究. 军事科学院, 2019.
- 3. 刘丽娜, 赵宗正, 郭振东, 等. 人感染H5N6亚型禽流感病毒研究进展. 军事医学, 2017, 41(1): 69-72.
- 4. Surveillance Division of the Communicable Disease Branch of the Centre for Health Protection (2023). Avian Influenza Report, volume 19 (China: Department of Health, Government of the Hong Kong Special Administrative Region), number 30. https://www.chp.gov.hk/files/pdf/ 2023_avian_influenza_report_vol19_wk30.pdf.
- 5. Pan M, Gao R, Lv Q, et al. Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: Virological and clinical findings. J Infect, 2016, 72(1): 52-59.
- 6. Steven JL, Vincent AP, Warwick B, et al. Extracorporeal membrane oxygenation. Med J Aust, 2009, 191(3): 178-182.
- 7. 张伟明, 方树珊, 唐松元, 等. 奥司他韦对高致病性H5N6亚型禽流感病毒的抑制效果评价. 现代畜牧兽医, 2019(8): 12-16.
- 8. Guan W, Qu R, Shen L, et al. Baloxavir marboxil use for critical human infection of avian influenza A H5N6 virus. Med, 2024, 5(1): 32-41.
- 9. Wu W, Shi Y, Gao H, et al. Immune derangement occurs in patients with H7N9 avian influenza. Crit Care, 2014, 18(2): R43.
